Historical review from 2026-11-14. Current price and availability are unconfirmed; check the original marketplace.

← Back to 2026-11-14 Deals
#19

Stacker: Peptide Tracker

Health & FitnessListed on TrustMRR· Nov 2
$15.0K
Asking Price
$446/mo
Monthly Revenue
$437/mo
Monthly Profit
2.9x
Profit Multiple
N/A
Business Age
✨

Why We Picked This

Stacker is a verified iPhone app in the health and fitness niche targeting the growing peptide-tracking market. The financials show exceptionally high margins (~98%) on $445/mo revenue, with a 2.86x annual profit multiple that sits at the lower end of reasonable for a mobile app. At $15,000 asking price, the absolute dollar commitment is modest, though the small revenue base ($437/mo profit) means any customer churn would have an outsized impact. The business age is not disclosed, which limits confidence in earnings durability, but the platform verification status adds meaningful credibility to the reported figures.

👍

Strengths

  • ✓Platform-verified financials — 98% profit margin on $445.84/mo revenue is consistent with a lean, low-overhead iOS app with minimal COGS
  • ✓Reasonable 2.86x annual profit multiple ($15K ask vs ~$5,244 annual profit) — below the 3x+ typical for established mobile apps
  • ✓Niche specificity (peptide stacking/tracking) targets an underserved, enthusiast-driven health audience with potential for word-of-mouth growth
  • ✓Modest acquisition price of $15,000 lowers absolute capital risk compared to most SaaS or content acquisitions
🔎

Details to confirm

  • •Business age is not disclosed — confirm launch date, revenue history by month, and whether the $437/mo profit is a recent average or a long-term trend
  • •Request App Store download count, monthly active users, and retention/churn metrics to understand the depth of the user base behind the revenue figures
  • •Clarify the monetization model (subscription vs. one-time purchase) and pricing tier structure, as recurring subscription revenue would substantially strengthen durability
  • •Confirm whether the $15K asking price includes any registered IP, App Store Connect account transfer process, and any existing backend infrastructure or third-party API dependencies

Additional details to confirm

Evidence 60/100
Business age unavailableUnusually high reported profit margin

Buy vs Build: BUY

52
AI-native cash cost
$2.0K–$5.5K
Estimated time
6 weeks
Asking price
$15.0K

A solo founder with AI coding tools (Cursor, Claude, Xcode templates) and a SwiftUI framework could reproduce the core peptide-tracking MVP — dose logging, reminders, protocol progress — in roughly 4–8 weeks at an estimated $2,000–$5,500 out-of-pocket (AI subscription, Apple Developer account, backend hosting, push notification service). The software itself is not a strong moat. However, the buy verdict is supported — narrowly — by the verified revenue, the niche App Store presence, and the modest $15K price tag that includes an operational customer base. Building from scratch would require re-acquiring App Store rankings, reviews, and an existing paying audience, which carries meaningful execution risk relative to the low acquisition cost. Missing user count and retention data prevent a higher confidence score, so buyers should request those metrics before closing.

Cash estimate includes the AI tools, APIs and infrastructure needed for a solo founder to recreate the software. Build time is informational and lightly weighted. The verdict is driven mainly by customers, users, verified earnings, retention, distribution, brand, data and operating history.

📊

Financial Snapshot

$5K
Annual Revenue
$5K
Annual Profit
$0.4K
Monthly Revenue
34 mo
Est. Payback
Profit Margin98%
📋

Business Overview

Helps users build personalized peptide stacks, log doses, get reminders, and track protocol progress and results in one iPhone app.

📌

Quick Facts

🏢
Type
Health & Fitness
🏪
Source
TrustMRR
📌
Listed
Nov 2, 2026

Deal Score

62
Interesting
Evidence confidence60/100
2.9x
Good Multiple
Asking$15.0K
MRR$446/mo
Profit$437/mo
Profit Multiple2.9x
View on TrustMRR →

Opens the original listing on TrustMRR

Share this review

Know a buyer or the founder? Send them the full analysis.

Share on X
New listings by email

See tomorrow’s businesses for sale.

Get new listings with asking prices, monthly profit, deal scores, and key risks.

The best reviewed deals, concise and evidence-first. Unsubscribe anytime.

Preliminary screening based on marketplace and public data. Verify all financial, legal, technical, customer, and operational claims independently before making an acquisition decision. This is not financial or legal advice.